Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration
about
Tau StructuresAutophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.Fasudil attenuates aggregation of α-synuclein in models of Parkinson's diseaseRho Kinase Inhibition with Fasudil in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis-Symptomatic Treatment Potential after Disease Onset.Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.T cells and IL-17 in lupus nephritis.A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies.Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease.Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.Drk-mediated signaling to Rho kinase is required for anesthesia-resistant memory in Drosophila.Tau-based therapies in neurodegeneration: opportunities and challenges.Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation.Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.A role for APP in Wnt signalling links synapse loss with β-amyloid production
P2860
Q28076921-74966C21-5B91-47E1-A902-A83DC4CC8B51Q36639242-7EA89571-DA29-4915-BAE7-78FB55207EC0Q36825541-4000E97B-632C-40B1-A00B-5F04E9201509Q37614522-5065ED01-5A60-4EAA-A845-576ABE85097AQ38666247-5DFA86BB-E5F4-4770-875A-765C3CE4C800Q38816316-5B22EDCC-FD16-44DD-8222-E884A458CEDCQ39270980-39B6DD6F-4D7F-4B22-A07E-AD110FF6580AQ39444002-C96737D1-B795-4CDF-9F1C-A6E33471C9B7Q42365681-21C8813A-00D1-4B14-BD1B-28F8C9A896ACQ47245894-A97C1D7F-4D29-45F5-BE8C-AF1C5009CD24Q47689697-B1C1ADBE-C6C3-4DFB-91AC-B0D9F2723151Q47867970-F8BB7849-361D-4A0B-8844-BFA351CC3A3CQ54223105-655E23D4-A8F8-454E-A8FF-B1BBA5BC6D35Q58714162-7601E20F-963A-492D-B624-F1265CAABA38
P2860
Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration
description
2016 nî lūn-bûn
@nan
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
name
Rho Kinase Inhibition as a The ...... and Corticobasal Degeneration
@ast
Rho Kinase Inhibition as a The ...... and Corticobasal Degeneration
@en
type
label
Rho Kinase Inhibition as a The ...... and Corticobasal Degeneration
@ast
Rho Kinase Inhibition as a The ...... and Corticobasal Degeneration
@en
prefLabel
Rho Kinase Inhibition as a The ...... and Corticobasal Degeneration
@ast
Rho Kinase Inhibition as a The ...... and Corticobasal Degeneration
@en
P2093
P2860
P1476
Rho Kinase Inhibition as a The ...... and Corticobasal Degeneration
@en
P2093
Andrew E Arrant
Benjamin W Henderson
Erik G Gentry
Jeremy H Herskowitz
Yangbo Feng
P2860
P304
P356
10.1523/JNEUROSCI.2336-15.2016
P407
P577
2016-01-01T00:00:00Z